Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Patient Insights into the Design of Technology to Support a Strengths-Based Approach to Health Care.

SURVEY: Weight Management & Chronic Illness

Japanese green tea consumers have reduced risk of dementia

Do Nothing, Accomplish Everything! The Connection Between Breathing and Healing

Best Herbs to Help With Insomnia

Nature Heals

Meet the ProHealth Editors

Choline: Why You Should Eat Your Egg Yolks and Take Krill

Calcium, vitamin D supplementation associated improved stroke recovery

Acupressure reduced fatigue in breast cancer survivors

 
Print Page
Email Article

Effect of adding milnacipran to pregabalin in the management of fibromyalgia: A randomized, open-label, controlled study – Source: Presentation at American Pain Society Annual Meeting, May 6-8 2010

  [ 58 votes ]   [ Discuss This Article ]
By Mildred Farmer, et al. • www.ProHealth.com • May 19, 2010


Clinical practice guidelines for treatment of fibromyalgia (FM) emphasize the role of pharmacologic interventions that address multiple symptoms, such as pain, fatigue, and sleep disturbance. Patients with FM may benefit from a combination of medications with complementary mechanisms of action that could yield additive or synergistic effects.

A rational combination therapy approach would be:

• Milnacipran [brand name Savella®], a dual reuptake inhibitor thought to augment norepinephrine and serotonin neurotransmitter signaling in descending pain modulatory neurons,

• Plus pregabalin [brand name Lyrica®), which may inhibit nociceptive signaling in ascending fibers through voltage-gated calcium channels.

This randomized, open-label, controlled study evaluated the efficacy and tolerability of milnacipran 50 mg BID when added to pregabalin 150 mg BID or 225 mg BID in FM patients who had an incomplete response to pregabalin during a 4- to 12-week open-label run-in phase.

Pregabalin incomplete responders (defined as patients with weekly recall VAS pain score 40 or more and 90 or less [0 to 100 scale], Patient Global Impression of Severity score 4 or more [moderately ill], and Patient Global Impression of Change [PGIC] score 3 or more [minimally improved]) were randomized to either pregabalin alone (n=179) or milnacipran with pregabalin (n=184) for 11 weeks.

The primary endpoint was an ITT responder analysis, with responders defined as patients reporting a PGIC score of “1” or “2” at endpoint.

• Significantly more patients receiving combination therapy were PGIC responders than patients receiving pregabalin alone.

• The addition of milnacipran to pregabalin also resulted in significantly greater reductions in mean weekly recall VAS pain scores.

• Approximately one-third of patients discontinued the study,

• With fewer patients discontinuing from the milnacipran with pregabalin combination group than pregabalin alone.

This was the first randomized controlled study to demonstrate that adding milnacipran to pregabalin therapy was tolerable and effective in improving global status and reducing pain in patients with FM. (Supported by Forest Laboratories, Inc. and Cypress Bioscience, Inc.)

Source: Presentation (Abstract #215) at American Pain Society Annual Meeting, May 6-8, 2010. By Farmer M, Dayani N, Trugman J, Wang Y, Gendreau R. Forest Research Institute and Cypress Bioscience, Inc., Jersey City, New Jersey and San Diego, California, USA.





Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10 Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10
Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask
Bone Broth Benefits for Digestion, Arthritis and Cellulite Bone Broth Benefits for Digestion, Arthritis and Cellulite
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol
Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map